Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Option Care Health ( (OPCH) ) has shared an announcement.
Option Care Health has announced preliminary financial results for the fourth quarter and full year 2024, with expected net revenue growth of up to 20.1% for the quarter and 16.2% for the year. The company also introduced a new $500 million stock repurchase program and provided guidance for 2025, anticipating revenues between $5.2 billion and $5.4 billion, despite expected negative impacts from pricing adjustments on Stelara. This reflects the company’s strategic efforts to enhance shareholder value and sustain growth in a competitive healthcare market.
More about Option Care Health
Option Care Health is the nation’s largest independent provider of home and alternate site infusion services, operating across all 50 states with over 8,000 team members, including more than 5,000 clinicians. The company focuses on elevating care standards for patients with acute and chronic conditions through clinical leadership and expertise.
YTD Price Performance: 5.68%
Average Trading Volume: 2,153,113
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $4.08B
For a thorough assessment of OPCH stock, go to TipRanks’ Stock Analysis page.
